主页 > 生命科学 >
【每日动态】每日生物医药动态报道, 3月6日
Gilead Sciences removes warning for Letairis Yahoo/AP Sat, 03/05/11 - 12:05 pm
tags: Gilead Sciences, Letairis
All Eyes Are On Roche, Avastin And Lucentis Pharmalot Fri, 03/04/11 - 1:03 pm
tags: Avastin, diabetic macular edema, Lucentis, Roche
A Victory For Gilead Forbes Fri, 03/04/11 - 1:01 pm
tags: Gilead, HIV, Myogen
BioSante expects to support drug study program with $23.8 million from direct stock offering Yahoo/AP Fri, 03/04/11 - 1:00 pm
tags: BioSante, Pfizer, stock offering
Genzyme CEO: Sanofi to create jobs Boston Herald, MA Fri, 03/04/11 - 10:44 am
tags: Genzyme, Henri Termeer, M&A, Sanofi-Aventis
Merck Discriminated Against A Non-Hispanic Worker? Pharmalot Fri, 03/04/11 - 10:42 am
tags: discrimination, Merck
Vivus Shares Fall 13 Percent After FDA Topamax Risk Warning Bloomberg Fri, 03/04/11 - 10:40 am
tags: birth defects, J&J, Qnexa, Topamax, Vivus
Somaxon's 4Q loss widens on higher costs Yahoo/AP Fri, 03/04/11 - 10:39 am
tags: earnings, Somaxon
Sucampo reports loss on revenue dip, higher costs Yahoo/AP Fri, 03/04/11 - 10:38 am
tags: earnings, Sucampo
No Serendipity Involved in Vertex's Achievements Seeking Alpha Fri, 03/04/11 - 10:37 am
tags: cystic fibrosis, Vertex, VX-770
Novartis Lung Treatment Faces Scrutiny in Second Review by FDA
阅读本文的人还阅读：
作者:admin@医学,生命科学 2011-03-06 11:24
医学,生命科学网